Second, we compared the therapeutic efficacy of the Cat-S inhibitor RO5459072 with MMF at a dose proven to efficiently control SLE and lupus nephritis of MRL-(Fas)lpr mice24–26. Here, PIMREG is linked to lupus nephritis.